Geniposideはインスリン抵抗性および肝繊維症をインスリンシグナル伝達経路によって軽減する
Seung-Hyun Oh1, Min-Seong Lee1, Byung-Cheol Lee1
1Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.
International journal of molecular sciences
|August 28, 2025
まとめ
Geniposide (GP) は,インスリン感受性を改善し,マウスの肝炎と線維症を軽減することによって,非アルコール性脂肪肝炎 (NASH) を効果的に治療します. この天然の化合物は 代謝障害の治療の可能性を示しています
科学分野:
- メタボリック障害
- ヘパトロジー
- 薬理学について
背景:
- インスリン抵抗性は2型糖尿病や非アルコール性脂肪肝 (NAFLD) などの代謝障害を引き起こし,非アルコール性脂肪肝炎 (NASH) に進行する可能性があります.
- 高脂肪食 (HFD) は,疾患のメカニズムと潜在的な治療法を研究するための研究でNASHモデルを誘発するために一般的に使用されます.
研究 の 目的:
- HFD誘発のNASHマウスモデルにおけるインスリン抵抗性および肝繊維症に対するジェニポシド (GP) の治療効果を調査する.
- 代謝と炎症経路に対するGPの作用の基礎となる分子メカニズムを解明する.
主な方法:
- C57BL/6マウスはHFDを投与し,GP (50 mg/ kg,100 mg/ kg) または対照群を12週間投与した.
- 評価には体重,脂肪量,グルコース/脂質代謝検査 (経口グルコース耐性検査,HOMA- IR,血脂検査),肝臓組織学,炎症およびインスリンシグナリングマーカーの遺伝子発現分析 (qRT- PCR) が含まれていた.
主要な成果:
- 食事の摂取に影響を与えることなく,GPの治療で体重,頭皮の脂肪,肝臓の体重が著しく減少しました.
- 血糖と脂質代謝の改善,抑制された脂肪細胞高縮,肝臓脂質の蓄積,および線維症が観察されました.
- 炎症マーカー (F4/80,TNF-α,IL-6) とインスリンシグナル伝達経路遺伝子 (JAK2,INSR,IRS-2,AKT1) を調節し,AMPK発現を強めた.
結論:
- Geniposideは,インスリン感受性を改善し,炎症を軽減し,肝繊維症を緩和することにより,NASHに対する重要な治療の可能性を示しています.
- GPは部分的にINSR-IRS2-Akt経路を活性化し,AMPK発現を高め,代謝障害に対する有望な天然化合物を提供します.
関連する概念動画
Dipeptidyl Peptidase 4 Inhibitors
252
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
252
Insulin: The Receptor and Signaling Pathways
1.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones
288
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
288
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
Oral Hypoglycemic Agents: Glinides
256
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
256
Insulin: Biosynthesis, Chemistry, and Preparation
518
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
518


